NCT05740683Recruiting
Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
Source: ClinicalTrials.gov · Last updated 2 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Test of early warning signs and RT-QuIC in patients with idiopathic olfactory dysfunction
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 13 Feb 2023
- Start date
- Feb 2023
- Primary completion date
- Dec 2032
- Lead sponsor
- Danish Dementia Research Centre
- Diseases
- Lewy body dementia, Parkinson disease
- NCT number
- NCT05740683
What you commit to
- Study type: Observational
- Planned participants: 100
- From Feb 2023 to the primary completion date, Dec 2032
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Olfactory dysfunction with response to systemic or local corticosteroids if tried
- Current alcohol or drug abuse
- Current alcohol or drug abuse
Other illness
- Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition.
- Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function.
- Severe nasal cavity abnormalities or infections.
- Overt signs of dementia or PD
- Terminal illness
- Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
- Overt signs of dementia or PD
- Severe nasal cavity abnormalities or infections.
- Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Other
- Olfactory dysfunction on clinical test
Who the study is looking for
- Age 55 -75 years of age
- Slowly progressing and non-fluctuating iOD
- Able to give informed consent and to cooperate as evaluated by the PI
- Age 55 -75 years of age
- Able to give informed consent
- Able to cooperate as evaluated by the PI
Age in the registry: 55 years to 75 years · Sex: All
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oskar McWilliam Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
| Danish Dementia Research Centre Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.